RE:COVID Nasal vaccineThe only problem with all of this enriquesuave, is the fact that our TLD-1433 is a very expensive formula to produce. If we go around saying we can also be a vacine, will limit the fees we can charge down the road for cancer treatments. I highly doubt the population or Gov's will pay $thousands per vacine, but then again maybe they will ? I suppose the real question would be how much volume of 1433 would be required to be effective if it works? Personally I'd like to see us focus on getting the NMIBC treatment perfected, and quickly into the market. I'm hoping the company is not planning on using warrant money to complete the trial, because that would be an unknown, and certainly can not be counted on as we have all experienced with this depressing investment !